Search research articles

Search research articles

Related Experiment Videos

Novel streptogramin antibiotics.

G Bonfiglio¹, P M Furneri

¹Dipartimento di Scienze Microbiologiche, Università di Catania, Via Androne 81, 95124 Catania, Italy. bonfigio@mbox.unict.it

Expert Opinion on Investigational Drugs

|February 15, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sub-picosecond exchange-relaxation in the compensated ferrimagnet Mn<sub>2</sub>Ru<sub></sub>Ga.

Journal of physics. Condensed matter : an Institute of Physics journal·2021

Same author

Dual-drugs delivery in solid lipid nanoparticles for the treatment of Candida albicans mycosis.

Colloids and surfaces. B, Biointerfaces·2019

Same author

Biological properties of Cakile maritima Scop. (Brassicaceae) extracts.

European review for medical and pharmacological sciences·2019

Same author

Biological properties and production of bacteriocins-like-inhibitory substances by Lactobacillus sp. strains from human vagina.

Journal of applied microbiology·2018

Same author

Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy.

Colloids and surfaces. B, Biointerfaces·2018

Same author

Growth and adhesion to HT-29 cells inhibition of Gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination.

European review for medical and pharmacological sciences·2016

Same journal

Advancements in longevity pharmacology research - are we finally seeing clinical progression?

Expert opinion on investigational drugs·2026

Same journal

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Expert opinion on investigational drugs·2026

Same journal

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

Expert opinion on investigational drugs·2026

Same journal

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

Expert opinion on investigational drugs·2026

Same journal

Odronextamab: a bispecific antibody for follicular lymphoma.

Expert opinion on investigational drugs·2026

Same journal

Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Expert opinion on investigational drugs·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Streptogramins are unique antibiotics that inhibit bacterial protein synthesis. Water-soluble derivatives overcome solubility issues, offering new treatments for multi-drug resistant Gram-positive bacterial infections.

Area of Science:

Microbiology
Pharmacology
Medicinal Chemistry

Background:

Streptogramins are natural antibiotics from Streptomyces species, classified into Group A (macrolactones) and Group B (cyclic hexadepsipeptides).
They inhibit bacterial protein synthesis by binding to ribosomes and act synergistically.
Natural streptogramins had poor water solubility, limiting therapeutic applications.

Purpose of the Study:

To highlight the unique antibacterial properties and mechanism of action of streptogramins.
To discuss the development of water-soluble streptogramin derivatives to overcome limitations.
To emphasize their potential in treating multi-drug resistant Gram-positive bacterial infections.

Main Methods:

Classification of streptogramins into Group A and Group B based on structure.

Related Experiment Videos

Investigation of their synergistic action on bacterial ribosomes and protein synthesis inhibition.

Synthesis of water-soluble derivatives, leading to injectable (quinupristin/dalfopristin) and oral formulations (RPR-106972).

Main Results:

Streptogramins A and B exhibit synergistic antibacterial activity in vitro and in vivo.
The combined action is irreversible and more potent than individual components.
Water-soluble derivatives have enabled injectable and oral formulations with demonstrated activity against multi-drug resistant Gram-positive bacteria.

Conclusions:

Streptogramins are potent antibiotics with a unique mechanism, effective against resistant Gram-positive pathogens.
Development of soluble derivatives has expanded their therapeutic utility.
Their lack of cross-resistance with other antibiotic classes makes them valuable for combating resistant infections.